Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Aquestive Therapeutics, Inc. (AQST)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.1700+0.0500 (+4.46%)
At close: 04:00PM EDT
1.1600 -0.01 (-0.85%)
After hours: 07:54PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Benzinga

    Aquestive Inks Supply Pact For Its Seizure Treatment Covering European, Middle East Countries

    Aquestive Therapeutics Inc (NASDAQ: AQST) entered a license and supply agreement with Pharmanovia for Libervant (diazepam) Buccal Film across the European Union, the U.K., Switzerland, and Norway, as well as countries in the Middle East and North Africa (MENA). Libervant is used to treat prolonged or acute, convulsive seizures of all ages. "Libervant has the distinct advantage of being readily administered when needed without regard to food, which is essential to patients as rapid and extensive

  • GlobeNewswire

    Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets

    WARREN, N.J., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive”), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, today announced it has entered a license, and supply agreement for Libervant™ (diazepam) Buccal Film with Pharmanovia, a global lifecycle management healthcare company, for treatment of prolonged or acute, convulsive seizures in

  • Benzinga

    Aquestive's AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction

    Aquestive Therapeutics Inc (NASDAQ: AQST) announced positive topline results from the EPIPHAST 2 trial for its AQST-109 epinephrine sublingual film. The trial was designed to compare single doses of AQST-109 to EpiPen 0.3mg and epinephrine 0.3mg intramuscular (IM) injection and repeat doses of AQST-109 to repeat doses of epinephrine 0.3mg IM injection. EpiPen auto-injectors are used for allergic emergencies. Related: Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allerg

Advertisement
Advertisement